Please assess the completion status of the following clinical trial:

Trial Title: Implantation of Markers for the Radiotherapy of Lung Cancer Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Diagnosis of non-small cell lung cancer~  * Stage I-IIIB disease~* No prior surgical tumor resection~* Respiration-induced tumor motion \> 5 mm~* Recruited by attending physician or research nurse at the Medical College of Virginia Hospitals~PATIENT CHARACTERISTICS:~* Not pregnant~* No insufficient lung function or other parameters prohibiting a bronchoscopy~* Not a prisoner or institutionalized~PRIOR CONCURRENT THERAPY:~* See Disease Characteristics~* Concurrent chemotherapy allowed

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Diagnostic (Type: EXPERIMENTAL): Patients undergo implantation of radio-opaque markers into the primary lesion and affected lymph nodes by bronchoscopy. Patients then undergo routine 4D CT, 4D CBCT, fluoroscopy, and x-ray imaging during standard stereotactic radiation therapy (early stage tumors) or conventionally fractionated radiation therapy (advanced stage tumors).

Based on this trial design, predict the completion outcome and termination type (if applicable).